Zeynep Eroglu MD
Medical Oncologist, Department of Cutaneous Oncology, Moffitt Cancer Center; Assistant Professor, Department of Oncologic Sciences, University of South Florida Morsani College of Medicine, Tampa, Florida
Dr. Eroglu is a medical oncologist in the Department of Cutaneous Oncology at Moffitt Cancer Center and an assistant professor in the Department of Oncologic Sciences at the University of South Florida Morsani College of Medicine. Her clinical focus is on treating patients with advanced melanoma and other skin cancers, including basal cell carcinoma and Merkel cell carcinoma, and participating in clinical trials. Dr. Eroglu’s research interests are translational and clinical research in targeted therapies and combination immunotherapeutics for melanoma and other skin cancers, along with development of personalized treatment strategies and biomarkers for patients with melanoma.
Recent Contributions to PracticeUpdate:
- Atezolizumab, Vemurafenib, and Cobimetinib as First-Line Treatment for Unresectable Advanced BRAFV600 Mutation–Positive Melanoma
- Adjuvant Nivolumab Plus Ipilimumab or Nivolumab Monotherapy vs Placebo in Patients With Resected Stage IV Melanoma With No Evidence of Disease
- The EORTC-DeCOG Nomogram Adequately Predicts Outcomes of Patients With SLN+ Melanoma
- Management of Early Melanoma Recurrence Despite Adjuvant Anti–PD-1 Antibody Therapy
- ASCO 2020: Abstract Recommendations From Dr. Zeynep Eroglu for Melanoma
- Melanoma in the COVID-19 Era: Advanced Metastatic Setting
- Melanoma in the COVID-19 Era: Metastatic Cancers
- Melanoma in the COVID-19 Era: Adjuvant Therapy
- Survival of Patients With Advanced Metastatic Melanoma
- Incidence and Predictors of CNS Metastasis for Patients With AJCC 8th Edition Stage III Melanoma